U.S. stock index futures remained muted on Tuesday following a sharp rally in the previous session as tech stocks bounced off a bruising rout, with investors looking out for retail sales numbers that kick off a series of key data releases this week. .N

** Regenxbio Inc RGNX.O:BUZZ - Drops after FDA rejects gene therapy for rare disease nL6N3Y90IU

** Fluence Energy Inc FLNC.O:BUZZ - Rises as Jefferies upgrades to 'buy' on demand recovery nL6N3Z60LP

** Coca-Cola Co KO.N:BUZZ - Q4 EPS, rev seen rising nL6N3Z513C

** Upwork Inc UPWK.O:BUZZ - Tumbles after Q1 outlook disappoints nL4N3Z60VO

** Becton Dickinson and Co BDX.N:BUZZ - Falls after lowering profit forecast nL4N3Z60XP

** FTAI Aviation Ltd FTAI.O:BUZZ - Jefferies raises FTAI Aviation PT as power business gains momentum nL4N3Z60Y9

** Hecla Mining Co HL.N:

** Coeur Mining Inc CDE.N:

** Endeavour Silver Corp EXK.N:

** Abrdn Physical Silver Shares ETF SIVR.N:

BUZZ - Silver miners fall as increased risk appetite lifts global equities nL6N3Z60OS

** Spotify Inc SPOT.N:BUZZ - Jumps after upbeat profit forecast nL4N3Z6104

** DuPont De Nemours Inc DD.N:BUZZ - Gains on upbeat 2026 profit forecast nL4N3Z6119

** Under Armour Inc UAA.N:BUZZ - Falls after Citigroup downgrades to 'sell' nL6N3Z60P6

** Willis Tower Watson PLC WTW.O:BUZZ - U.S. insurance brokers steady after slumping on AI disruption risks nL6N3Z60MI

** Hims & Hers Health Inc HIMS.N:BUZZ - Falls after Novo Nordisk sues co for patent infringement nL6N3Z60P3

** Oscar Health Inc OSCR.N:BUZZ - Shares fall on Q4 revenue miss nL4N3Z611S

** Dakota Gold Corp DC.N:BUZZ - Slides on $75 mln stock sale nL6N3Z60PV

** Personalis Inc PSNL.O:BUZZ - Rises as Medicare extends coverage to lung cancer test nL4N3Z6136

** FedEx Corp FDX.N:BUZZ - Barclays raises FedEx PT on AI-fueled growth expectation nL4N3Z610V

** Hasbro Inc HAS.O:BUZZ - Rises after Q4 revenue beat nL4N3Z6142

** Wingstop Inc WING.O:BUZZ - Shares dip as at least two brokerages downgrade stock nL6N3Z60OH

** Tectonic Therapeutic Inc TECX.O:BUZZ - Shares plunge as AstraZeneca scraps rival relaxin drug nL4N3Z6150

(Compiled by Rajarshi Roy and Dharna Bafna)

((Rajarshi.Roy@thomsonreuters.com))